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Purpose: To assess the neuroprotective effect of CD 34+ stem cells on retinal ganglion cell (RGC) survival after optic 
nerve compression injury (ONCI). 
Methods: The optic nerve compression injury was obtained through exerting pressure on the optic nerve 1 mm behind 
the eye globe for duration of 60 seconds. This compression was conducted using a stereotactic device attached to small 
forceps after good exposure to optic nerve. Treatment of ONCI model was done through intravenous administration of 
3,000,000 CD34+ stem cells intravenous through rat tail was done six hours after the onset of the nerve crush injury. 
Evaluation of the effect of CD34 positive stem cells on injured retinal cells was obtained 6 days after ONCI through the 
following: (1) immunohistochemistry through Brn-3b labelled RGCs and, (2) electrophysiological changes was studied 
using F-VEPS after dark adaptation period. 
Results: Brn-3b labeled RGCs density was found with an average of 1490 /70074 µm² in the normal retina of adult 
female Wistar rat animal, in compared to 366 / 70074 µm² in the retina of non treated ONCI. Flash–Visual Evoked 
potentials (f-VEPs) were prolonged from 50 msec in control rats to 110 msec in experimental rats after treatment with 
stem cells, there was an increase in the number of RGCs with an average of 999 / 70074 μm² and reduction in the latency 
of F. VEPs to 91 msec in the CD 34 + treated group. 
Conclusion: Intravenous administration of 3,000,000 human umbilical cord blood CD 34+ stem cells may have a 
potential neuroprotective effect on damage/injured retinal ganglion cells manifested by an increase in the survival of 
retinal ganglion cells (56%)and an improvement in the latency period of f-VEPs in the optic nerve compression injury 
model treated with stem cells (33%). 
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Abbreviations: ONCI: Optic Nerve Compression 
Injury; RGC: Retinal Ganglion Cell; IOP: Intraocular 
Pressure; SCI: Spinal Cord Injury 
 
Introduction 
     World Health Organization statistics indicates that 
glaucoma accounts for blindness of at least 5 million 
people, causing 13.5% world blindness. In unites States, 
glaucoma is the second leading cause of blindness and the 
second most frequent reason for ambulatory visits to 
physician in US. In glaucoma, progressive death of Retinal 
Ganglion Cells (RGCs) leads to optic nerve degeneration 
and progressive loss of vision. The main lines of glaucoma 
treatment focus on reduction of intraocular pressure 
(IOP) either surgically or pharmacologically. There are 
strong evidences that lowering IOP provides 
neuroprotective effects on injured RGCs. Even with a 
controlled IOP, there is a progressive loss of RGCs. 
Consequently, there is an increase need for 
neuroprotective agents that may preserver RGCs in the 
presence of normal IOP in glaucoma patients.  
 
     The optic nerve compression injury (ONCI) has served 
as an important model for studying the non-neuronal 
response to an injury and for studying axon regeneration 
in the CNS [1-4]. It is also a well-established model to 
study glaucoma and RGCs. ONCI leads to death of RGCs as 
a direct result of primary damage to the axons secondary 
to the disruption of retrograde axonal transport [5]. 
Additional damage is caused by “secondary degeneration” 
of RGCs that escaped direct injury, but are susceptible to 
damage by different toxic mediators released into the 
extracellular environment by dying RGCs.  
 
     We focused in this experiment on restoring injured 
RGCs after ONCI through the use of Human umbilical cord 
blood stem cells (hUCBCSs). hUCBCSs are one of the 
strongest candidates used in cell therapy for spinal cord 
injury (SCI) because of its greater availability, weak 
immunogenicity, and lower risk of viral transmission [6]. 
The goal of this study is investigate the neuroprotective 
effects of hUCBCSsCD34+on adult rat after optic nerve 
compression injury. The neuroprotective effects of 
hUCBCSsCD34+ were assessed based on survival of RGCs 
and improvement in the latency time of F-VEPs. 
 
Material and Methods 
     All experiments were performed in accordance with 
the ARVO Statement for the Use of Animals in Ophthalmic 
and Vision Research, and Animal Care and Use Committee 
requirements. In this study, we used adult female Wistar 
rat animals, as they have been known to be sensitive to 
optic nerve trauma based on the level of Glutamate mRNA 
[7,8]. In addition, Wistar rat animals have been used 
extensively in experimental ophthalmology and visual 
science for evaluation of different lines of treatment.  
 
     In this study, we aimed to evaluate the neuroprotective 
effect of hUCBCSsCD34+oninjured RGCs after optic nerve 
compression injury. We compared the neuroprotective 
effect of hUCBCSsCD34+on three different groups of 
animals:  
(i) Group A, normal animals without any ONCI. 
(ii) Group B, animals exposed to ONCI for one minute 
without stem cell therapy. 
(iii) Group C, animals who were exposed to ONCI for one 
minute then treated for six hours after the onset of 
compression injury with 3,000,000 hUCBCSsCD34+.  
 
     The evaluation was conducted using 
immunohistochemistry to assess RGCs densities and the 
functional analysis we used electrophysiological function, 
f-VEPs, to measure the latency of flash visual evoked 
potential. 
 
Optic Nerve Compression Injury Device 
     Our group built a simple device to provide a uniform 
amount of optic nerve damage. This optic nerve 
compression injury device was composed of blunt forceps 
attached and manipulated by a stereotaxic device 
manipulator. This model provided a more uniform 
amount of pressure on optic nerve rather than other 
maneuvers. After good exposure of the optic nerve 
through fine dissection of the surrounding tissues, the 
forceps was applied for one minute directly between the 
meanings and the optic nerve just one mm behind the eye 
globe to avoid injury of the capillary network. The 
micromanipulator was adjusted to enable the forceps to 
crush the optic nerve without any change in the amount 
of force-applied force exerted on the optic nerve [9]. This 
model was used to simulate mechanical non-ischemic 
trauma to the optic nerve. 
 
Optic Nerve Compression Injury 
     Adult female Wistar rats were used with an average 
weight of 200-250 gm and average age of 2 to 3 months. 
The animals were anesthetized with 10 mg/Kg Xylazine 
(Phoenix Pharmaceutical, St. Joseph, MO) and 80 mg 
Ketamin (Pfizer Parke-Davis, Morris Plain, NJ). 
Sterilization of the surgical field was done using Betadine. 
Topical anesthetic drops were used to the cornea five 
minutes before the surgery using 0.5% proparacaine 
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(Alcaine, Ophthetic, Paracaine). The head was fixed in a 
stereotaxic frame and the surgical procedure was 
conducted through obtaining a good exposure of the optic 
nerve with minimum soft tissue damage and without 
injury to the surrounding blood vessels. We accessed the 
orbit through an incision in the lateral angle of the eye, a 
lateral canthatomy. The conjunctiva was dissected along 
the temporal limbus from 1 to 4 o'clock. 
 
     The eye globe was rotated nasally using a fixating 
suture (7-0 silk) through the conjunctiva and almost the 
entire Harderian gland was removed. While dislocating 
the eyeball anteriorly, the ocular muscles overlying the 
optic nerve was separated and held apart. The optic nerve 
was exposed by cutting the lateral rectus muscle and by 
blunt dissection of the tissue surrounding the optic nerve. 
Then with the aid of fine blunt scissors (used for 
tenotomy, Westcott), the tissues behind the eyeball and 
the extra ocular muscles around the optic nerve was 
dissected: the whole meninges were finely dissected along 
the optic nerve, while avoiding injury to the ophthalmic 
blood vessels. At this point, we had a good exposed 
portion of the optic nerve [10]. The meninges were cut 
sparing the surrounding blood vessels to have a good 
portion of the optic nerve. The compression injury was 
conducted 1 mm behind the eye globe for 60 seconds 
using the standard surgical forceps. 
 
     The skin and the conjunctiva were sutured using 4-0 
silk and 7-0 nylon, respectively. Postoperative care 
consisted of the following; (i) topical antibiotics: Ocuflox 
(Of loxacine) 0.3% 1-2 drops, once or as needed: (ii) 
topical anesthetics: proparacaine HCl 0.5% 1-2 drops, 
once or as needed: (iii) Carboxyl Methylcellulose: refresh 
celluvisc 1% once or as needed. We monitored the eye 
daily after the surgery to assess any signs of infection or 
rejection after hUCBCSsCD34 implantation such as 
corneal opacity, redness or intraocular hemorrhage.  
 
Immunohistochemistry  
     Brn-3b is a member of the POU-domain family of 
transcription factors that plays a critical role in regulating 
gene expression, particularly in cells of the nervous 
system [11]. Brn-3b has been found to be expressed in a 
sub-population of the RGCs nuclei of various species, 
including mouse, chicken, rabbit, monkey and human 
[12].  
 
Brn-3b Stained Retinal Ganglion Cell Positive 
Nuclei 
     Eyes were harvested from euthanized female Wistar 
rat and were dissected from the cornea, iris and lens. 
Eyecups were rinsed in saline before fixation. The whole 
eyes were fixed for at least two hours in 4% 
Paraformaldhyde in Dulbecco's phosphate buffered saline 
(Invitrogen 14200-075, Grand Island, USA). Eyes were 
transferred to tris buffered saline with Tween-20 (TBST) 
(Dako Cytomation S3306, Carpentaria, CA, USA) and 
dissected to obtain intact, flattened retina in a four-leaf 
clover shape. Vitreous was disrupt ted and removed 
manually by pinching and tearing vitreous using two pair 
of fine forceps. The retina was immersed in TBST in a 24 
well tissue culture plate (Costar, Corning, NY, USA) and 
was washed with successive rinse/drain cycles of TBST to 
remove the residual fixatives. Retina was permiabilized 
by 30-45 minutes incubation in 0.3%Triton X-100(X-100-
PC Sigma) in TBS, and then was washed three times with 
TBST to remove the detergent. Non specific binding of 
antibodies to resident retinal proteins were blocked by 
incubating the retina with 3% bovine serum albumin 
(BSA) (A-7030 Sigma) plus 10% normal donkey serum 
(017-000-121 Jackson Immuno- Research) in TBST for 30 
minutes with gentle agitation. If amplification of the BRN-
3b signal was desired, the endogenous retinal biotin 
(Bhattacharjee et al; Ruggiero and Sheffield) was also 
blocked using Avidin Biotin Block Kit (Vector Burlington, 
VT, USA) [11]. 
 
     The retina was incubated overnight with goat anti-
mouse Brn 3b (SC6026 Santa Cruz Bio-technology, Santa 
Cruz, CA, USA) and 3% BSA-TBST (1:50) at 4C with 
shaking balance, then wash was done using TBST for 15 
minutes with gentle agitation in 24 wheels. Retina was 
then incubated with 1:200 dilution of donkey-anti-goat 
biotin (705-065-1470) for two hours with gentle 
agitation. Again, another wash was done using TBST for 
15 minutes with gentle agitation in 24 wheels. 
 
     Amplification was obtained using a streptovidien Alexa 
594 (5-11227) molecular probe in TBST-3%BSA (1:400) 
for 30 minutes with gentle agitation. All retinal tissue was 
flattened on super frost plus microscope slide 12-550-15 
(Fischer Scientific, Pittsburgh, PA). Then mounting was 
done using an Anti Fade Kit (P-7481 Molecular Probs). 
Cover slides were added on the retinal tissue. After the 
slide dried, four areas circling the optic nerve from each 
retina were digitally imaged. We used a DAS Microscope 
LEICA DM IRB/E, which was mounted by SPOT RT color 
camera. ADVANCED SPOT software was used for image 
adjustment [13]. 
 
Image Capture and Analysis 
     The images were obtained using fluorescent 
microscopy (DAS Microscope LEICA DM IRB/E, which was 
Open Access Journal of Ophthalmology 
 
 
Amro Ali, et al. The Neuroprotective Effect of Human CD 34 Positive Stem Cells on the 
Survival of Injured Retinal Ganglion Cells. J Ophthalmol 2017, 2(4): 000133. 




mounted by SPOT RT color camera. ADVANCED SPOT 
software was used for image adjustment) by obtaining 
four different images in four different quadrants with the 
same distance from the optic disc to assure a uniform 
density of RGCs. Capturing of these images were obtained 
using 10X for better localization of the optic disc, then we 
had four different images in four different quadrants with 
an equal distance from the optic nerve to ensure the 
homogenous RGCs density using 40X lens power. 
Processing of these images were conducted using Spot 
Advanced Medicine Software (SPOT Imaging Solutions, a 
division of Diagnostic Instruments, Inc., 6540 Burroughs 
Sterling Heights, MI 48314, USA). 
 
     The images analysis was conducted using NIH-Soft 
image analysis J-1.33, which allowed us to analyze the 
fluorescent particle with an average size of 20-60 m 
square (2 to 6 pixels). The analyses of these images were 
done using the fast red fluorescent mode. This was started 
with subtraction of the background with enhancing of the 
contrast, which was followed by adjusting the threshold. 
Finally, the particles analysis was obtained with an 
average size of 2 to 6 pixels. The chosen four quadrants 
surface area is 700074 um² in comparison to the surface 
area of the whole retina of rat, which is 3.8 mm². 
 
Flash Visual Evoked Potential (f-VEPs) 
     F-VEP is a reliable method for testing the integrity of 
the visual pathway from the retina to cortex. The rats 
were deeply anesthetized with sodium pentobarbital (50 
mg/Kg) and placed into a stereotactic head frame device. 
Two holes were drilled through the skull of each animal, 
enabling two stainless steel frame screws to be placed in 
contact with the cortex serving as electrodes. The dura 
was kept intact to minimize the cortical damage. The 
“reference" and" active" electrodes positions were 5 mm 
anterior to the bregma, 1.5 mm left of the midline, and 8 
mm caudal to the bregma and 3 mm right of the midline, 
respectively. 
 
     F-VEP originates from the left eye, recorded in the right 
visual cortex, and was evoked by light stimulation after 
implantation of the electrodes. The xenon light source of a 
Grass PS22C Photic Stimulator was centered over the left 
eye at a distance of 10 cm, while the right eye was covered 
with black plastic tape to avoid the possibility of a VEP 
response originating from it. Single flash stimuli 10 m sec 
in duration were delivered in darkened room at an inter-
stimulus interval of approximately 10 sec with a peak 
light intensity of 19 million lumens. The signal from the 
reference and active electrode were differently amplified 
at a again of 1000, filtered between 1 and 100 Hz, and 
sampled digitally at 500 Hz. 
     F-VEPs measurements were recorded as a voltage 
fluctuation during a single 1000-msec sweep, where the 
beginning of each sweep coincided with triggering of light 
stimulus. Minimum of 60 individual measurements were 
collected and were presented as mean plus or minus 
standard of deviation. F-VEPs were done 6 days after 
optic nerve crush injury to the three groups of animals. 
These animal groups included the followings: (i) normal 
rats without crush injury, (ii) Sham control, non stem cells 
treated ONCI rats; and (iii) hUCBCSsCD34+treated ONCI 
rats. 
 
Stem Cell Isolation 
     Endothelial Progenitor Cells: Fresh whole blood was 
obtained from the human cord blood under an IRB 
approved protocol. Blood was collected in heparinized 
tubes. The blood was diluted 1:2 in phosphate buffered a 
line (PBS) plus 2 mM EDTA (Ethylene diaminetetra acetic 
acid), layered onto lymphocyte separation medium 
(Ficoll, density 1.077 g/ml, ICN Biomedical, Aurora, OH) 
and centrifuged for 30 minutes at 1,900 RPM, and at a 
temperature of 20°C (35 ml blood was very gently added 
onto 15 ml lymphocyte separation medium in every 50 ml 
sterile tube). Then the white ring fraction (mononuclear 
cell layer) was transferred to a new 50 ml tube using a 
sterile Pasteur pipette, PBS was added two times and the 
tubes were centrifuged for 15 minutes at 1500 RPM at 
room temperature. After discarding the supernatant, the 
pellet was resuspended in 4 ml ACKlysine buffer to get rid 
of (for lysing) remaining erythrocytes. Mononuclear cells 
(MNCs) were incubated in the ACK lysine buffer for no 
more than 3 minutes on ice. After 3 minutes, 20 ml PBS 
was added to the solution, the cells were washed twice 
(centrifuge at 1200 RPM) with PBS.  
 
     Mononuclear cells (MNCs) were subjected to 
immunomagnetic separation using an AC133 Cell 
Isolation Kit (Miltenyi Biotech; Auburn, CA; 
http://www.miltenyibiotec.com), according to published 
methods (45, 46). Briefly, MNCs were incubated for 45 
minuteson ice with an FcR-blocking reagent (human IgG) 
and AC 34MicroBeads. These micro beads are conjugated 
with monoclonal mouse anti-human antibodies against 
AC133. After washing with PBS plus 2 mM EDTA, the 
labeled cells were filtered through a 20-µm nylon mesh 
and loaded onto a column that was installed in a magnetic 
field. Trapped cells were eluted after the column was 
removed from the magnet. The collected cells were 
named as AC 34+ endothelial progenitor cells.  
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     Quantitative analysis of experimental animals was 
done for 6 rats 6 days after ONCI, two in each group. 
These rats showed no agitation or evidence of rejection 
following hUCBCSsCD34+transplantation. All rats 
survived the procedure including anesthesia, ONCI and 
stem cell intravenous administration without 
complications. Evaluation of the of the neuroprotective 
effects of hUCBCSsCD34+stem cell on survival of RGCs 
after optic nerve crush injury was studied by assessing 
Brn-3b labeled RGCs density in four different quadrants 
with the same distance from the optic nerve. 
 
     Brn-3b labeled RGCs density was 1490 /70074 µm in 
normal retina (Figures 1-3). In the sham-surgery group, 
Brn-3b labeled RGCs density was 366 /70074 µm (Figures 
4-6), Brn-3b labeled RGCs density was 999 /70074 µm in 
the retina of hUCBCSsCD34+treated ONCI model (Figures 
7,8,9). The number of RGCs was obviously reduced in the 
retina of the optic nerve crush injury model with an 
average of 366 /70074 µm, with a reduction of almost 
75% of RGCs of the normal retina. Brn-3b labeled RGCs 
density was obviously increased after systemic 
intravenous injection of 3,000,000 which was done 6 
post-ONCI, with an average of 999 /70074 µm in the 
treated group, with an increase in the survival of damaged 
RGC at a mean count of 633 /70074 µm, saving more than 
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Figure 7: Optic Nerve Compression Injury treated with 







Figure 8: Optic Nerve Compression Injury treated with 




Figure 9: Optic Nerve Compression Injury treated with 
stem Cells in animal 9. 
 
 
Flash -Visual Evoked Potentials 
     Flash -Visual Evoked Potentials was done for 6 rats 6 
days after ONCI, two in each group. Comparison of F-VEPs 
latencies between non treated ONCI and the stem cells 
treated ONCI group in comparison to normal rats without 
ONCI:) and the latency period was 50 ± 0.9 msec (Figure 
10) in normal rats. This result was compared to the the 
latency period of non treated ONCI model which was 110 
± 1.2 msec (Figure 11) and to the latency period of 
hUCBCSsCD34+ treated ONCI, which was 90 ± 1.1 msec 
(Figure 12). This revealed prolonged latency after ONCI, 
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Figure 11: Flash VEP on Optic Nerve Compression Injury 




Figure 12: Flash VEP on Optic Nerve Compression Injury 
group treated with Stem cells. Latency time=90msec. 
Discussion 
     We report for the first time that systemic intravenous 
administration of hUCBCs CD34+ have a neuroprotective 
effect on injured RGCs after ONCI: this effect was 
demonstrated by increasing the survival of retinal 
ganglion cells and improving the latency period of f-VEPs. 
In this study, optic nerve compression injury was 
accomplished using our previously described device (see 
methodology): this compression was occurred for 60 
seconds through applying the forceps on the optic nerve 1 
mm behind the eye globe. This compression injury to the 
axons of the neurons triggers degenerative responses. 
These degenerative reactions proceed retrograde to the 
soma and this is termed “Wallerian degeneration”. 
 
     After induction of ONCI, we injected 3,000,000 
hUCBCSsCD34+intravenously six hours after the onset of 
the crush injury. We performed Immunohistochemistry 
and electrophysiological studies days after ONCI to assess 
the neuroprotective effects. These neuroprotective effects 
could be attributed to the migration of the stem cells to 
the site of injury in response to chemotactic factors 
release, in this case the optic nerve trauma. The 
compression injury of the optic nerve leads to 
complement activation at the site of injury and along the 
distal portion of the nerve, as well as up regulation of the 
complement inhibitor Cluster in astrocytes. Reactive 
microglial cells seem to have a key role in complement 
activation as a local source of C3. It has been suggested 
that the balance between complement activation and 
their regulators may have an impact on axonal 
degeneration following opticnerve injury [14]. 
 
     In this study , intravenous administration of 3,000, 
000 hUCBSC CD34 + demonstrated neuroprotective 
effects on the optic nerve crush injury model presented 
with an increase in the survival of RGCs. Brn -3b labeled 
RGCs density was 1490 / 70074 μm in the normal retina 
in comparison to 366 / 70074 μm in the retina of non 
treated ONCI model. There was a loss of an average 1124 
/ 70074 μm. In the CD 34+ treated group, Brn-3b labeled 
RGCs density was only reduced to 999 / 70074 in 
comparison to the non-treated group where the average 
of RGCs was 491 / 70074 μm. Thus, 
immunohistochemistry study provides credence to the 
idea that CD34+ saved more than 505 / 70074 μm. 
 
     The average latency period of F-VEPs was 50 msec in 
normal retina in comparison to non-treated optic nerve 
compression injury at 110.6 msec. There was an 
improvement in the latency period of f-VEPS in the optic 
nerve compression injury model, which was treated with 
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3,000,000 CD 34+ stem cells with an average latency 
period of 91 msec, in comparison to the other ONCI non-
treated group with an average latency period of 110.6 
msec. As such, CD 34+ stem cell intravenous 
administration improved the conductivity in the visual 
pathway and presented with a shortening of the latency 
period by 19.6 msec.  
 
     The improvement in RGC survival and in f-VEPs could 
be attributed to neuroprotection rather than neuro-
differentiation due to difficulty in stem cell penetration of 
Bruch’s membrane. This study demonstrated the 
neuroprotective effect of stem cells but did not reveal 
their mechanisms. We will continue our work in this area 
exploring the underlying mechanism of neuro 
enhancement and neuroprotection. We will study the role 
of different neurotrophic and growth factors in 
neuroprotection. 
 
     Previous studies demonstrated the neuroprotective 
effects of neurotrophins on the development and the 
plasticity of the visual system of mammals and in 
particular the visual cortex. In addition, NGF was found to 
prevent all effects of monocular deprivation [15]. These 
neurotrophins: NGF, BDNF, NT3, and N4 have a wide 
range of effects in the development and the regeneration 
of the neuronal circuit of the visual system.  
 
     This study has few pitfalls, such as the small number of 
animals, absence of a positive control, and incomplete 
analysis of f-VEPs and lack of study on neuroprotective 
effect mechanisms through assessment of different 
neurotrophic factors. We will address these shortcomings 
in our future work. 
 
     This is a preliminary, but a promising experiment 
where we explored the complicated physiology of the 
neural circuit and how much hUCBCSsCD34+will have a 
contributing role in the neuroprotection of RGCs in 
compression optic neuropathy. Further work is required 
to assess the progression of apoptosis and if the presence 
of stem cell will delay or stop this process, progression of 
apoptosis. This will include assessment of different 
growth and neurotrophic factors levels such as BDNF, 
NGF, NT3, NT4/5, CNTF, GDNF in addition to 
neurotrophins’ surface receptors such as TrKA, 
Tropomyosin related kinase family and the p75 receptors. 
RGC die by apoptosis and this process were demonstrated 
in models of optic nerve compression injury or axotomy, 
experimental glaucoma and in human glaucoma. This 
apoptotic process is triggered by various stimuli. It 
involves intrinsic and extrinsic pathways which are the 
major area of research to prevent or delay RGC death in 
glaucoma (Molecular basis).  
 
Summary 
     We have demonstrated that intravenous 
administration of 3,000,000 hUCBCSsCD+ 34 stem cells 
have a significant impact on preserving of injured RGCs 
and retaining their electrophysiological functions. We 
found that 3,000,000 hUCBCSs CD+ 34 intravenous 
administrations preserve up to 63% of injured cells and 
improve latency time by 33 %.  
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